Showing results (11-20 of 95) with videos related to
Sort By:
Pageof 10
Clinical Trials (London, England)|August 14, 2018
Revisiting isotonic phase I design in the era of model-assisted dose-findingNolan A Wages, Mark R ConawayStatistics in Medicine|January 29, 2014
Phase I/II adaptive design for drug combination oncology trialsNolan A Wages, Mark R ConawayJournal of Biopharmaceutical Statistics|March 7, 2023
Dose-finding based on feasibility and late-onset toxicity in adoptive cell therapy trialsEvan M Bagley, Nolan A WagesStatistics in Medicine|September 15, 2016
Designs for phase I trials in ordered groupsMark R Conaway, Nolan A WagesBMC Cancer|February 7, 2018
A web tool for designing and conducting phase I trials using the continual reassessment methodNolan A Wages, Gina R PetroniContemporary Clinical Trials|April 1, 2025
Dose-finding designs for cell therapy cancer clinical trials evaluating drug-combinationsEvan M Bagley, Nolan A WagesJournal of Neuro-Oncology|June 24, 2021
Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphomaMiyabi Saito, Nolan A Wages, David SchiffJournal of Biopharmaceutical Statistics|September 18, 2015
Practical designs for Phase I combination studies in oncologyNolan A Wages, Anastasia Ivanova, Olga MarchenkoStatistica Sinica|January 16, 2023
SEMIPARAMETRIC DOSE FINDING METHODS FOR PARTIALLY ORDERED DRUG COMBINATIONSMatthieu Clertant, Nolan A Wages, John O'QuigleyClinical Trials (London, England)|October 3, 2013
Performance of two-stage continual reassessment method relative to an optimal benchmarkNolan A Wages, Mark R Conaway, John O'QuigleyPageof 10